We are live on ! Find out more
CAM

Claret Asset Management Portfolio holdings

AUM $928M
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
-0.83%
1 Year Est. Return
+25.4%
3 Year Est. Return
+73.27%
5 Year Est. Return
+90.16%
10 Year Est. Return
AUM
$487M
AUM Growth
+$3.42M
Cap. Flow
+$13.9M
Cap. Flow %
2.85%
Top 10 Hldgs %
38.1%
Holding
225
New
18
Increased
40
Reduced
123
Closed
26

Top Sells

Rank Stock Value
1
GIL icon
Gildan
GIL
+$3.41M
2
NTES icon
NetEase
NTES
+$1.84M
3
MSFT icon
Microsoft
MSFT
+$1.62M
4
SBH icon
Sally Beauty Holdings
SBH
+$1.33M
5
NOA
North American Construction
NOA
+$1.16M

Sector Composition

Rank Sector Weight
1 Technology 27.58%
2 Healthcare 19.51%
3 Financials 10.63%
4 Communication Services 8.92%
5 Consumer Discretionary 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIB icon
151
Grupo Cibest SA
CIB
$22B
$294K 0.06%
5,950
C icon
152
Citigroup
C
$222B
$277K 0.06%
4,005
-923
-19% -$62.8K
MOS icon
153
The Mosaic Company
MOS
$7.03B
$277K 0.06%
13,500
+4,500
+50% +$98K
ENDP
154
DELISTED
Endo International plc
ENDP
$274K 0.06%
85,236
-68,555
-45% -$221K
GOOS
155
Canada Goose Holdings
GOOS
$872M
$266K 0.05%
+6,046
New +$253K
KSU
156
DELISTED
Kansas City Southern
KSU
$257K 0.05%
+1,931
New +$241K
CNQ icon
157
Canadian Natural Resources
CNQ
$99.4B
$255K 0.05%
19,585
-7,371
-27% -$91.4K
JEF icon
158
Jefferies Financial Group
JEF
$12.6B
$252K 0.05%
14,316
-2,052
-13% -$36.5K
RCI icon
159
Rogers Communications
RCI
$18.3B
$252K 0.05%
5,176
-1,917
-27% -$98.7K
TAK icon
160
Takeda Pharmaceutical
TAK
$54.6B
$251K 0.05%
14,602
-1,982
-12% -$34.3K
BDX icon
161
Becton Dickinson
BDX
$45.6B
$247K 0.05%
1,001
-501
-33% -$124K
VLO icon
162
Valero Energy
VLO
$90.1B
$243K 0.05%
2,845
-215
-7% -$17.4K
COST icon
163
Costco
COST
$422B
$241K 0.05%
+835
New +$235K
ENDP
164
CALL
DELISTED
Endo International plc
ENDP
$241K 0.05%
3,500
+3,300
+1,650% +$10.6K
MA icon
165
Mastercard
MA
$502B
$239K 0.05%
880
VGT icon
166
Vanguard Information Technology ETF
VGT
$139B
$237K 0.05%
8,800
TUR icon
167
iShares MSCI Turkey ETF
TUR
$200M
$236K 0.05%
8,820
XLF icon
168
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
$234K 0.05%
8,367
VT icon
169
Vanguard Total World Stock ETF
VT
$77.1B
$232K 0.05%
3,100
FISV
170
Fiserv Inc
FISV
$28.8B
$228K 0.05%
+2,204
New +$225K
DIS icon
171
Walt Disney
DIS
$167B
$222K 0.05%
1,702
-293
-15% -$40.5K
CL icon
172
Colgate-Palmolive
CL
$73.1B
$217K 0.04%
2,954
-1,118
-27% -$81.1K
CMCSA icon
173
Comcast
CMCSA
$85B
$217K 0.04%
+4,818
New +$213K
RWX icon
174
State Street SPDR Dow Jones International Real Estate ETF
RWX
$269M
$213K 0.04%
5,400
UNH icon
175
UnitedHealth
UNH
$376B
$211K 0.04%
+971
New +$234K

Similar funds

Claret Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Claret Asset Management held 225 positions worth $487M, up 0.71% from $483M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Claret Asset Management's Q3 2019 filing shows 18 new, 40 increased, 123 reduced and 26 closed positions. Its largest new stake was Viemed Healthcare: 2,458,145 shares worth $17M. The largest sale was Gildan, an estimated $3.41M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Claret Asset Management's largest Q3 2019 buy was Viemed Healthcare: 2,458,145 shares worth $17M.
  • Claret Asset Management added most to Cognizant in Q3 2019, an estimated $2.45M increase.
  • Claret Asset Management's biggest Q3 2019 reduction was Gildan, cutting an estimated $3.41M.
  • Claret Asset Management fully exited Lannett Company, Inc. in Q3 2019, selling an estimated $702K.
  • Claret Asset Management's ten largest holdings make up 38% of its $487M portfolio in Q3 2019.
  • Claret Asset Management opened 18 new positions and closed 26 in Q3 2019.
  • Claret Asset Management's portfolio value rose 0.71% quarter-over-quarter to $487M.

Based on Claret Asset Management's 13F filing for Q3 2019, filed 11 Oct 2019.